LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 29.22%28.39M | 422.45%32.37M | 456.09%30.62M | 198.44%60.51M | 355.16%26.84M | 332.25%21.97M | 38.34%6.2M | 14.30%5.51M | 71.84%20.27M | 5.9M |
Operating revenue | 29.22%28.39M | 422.45%32.37M | 456.09%30.62M | 198.44%60.51M | 355.16%26.84M | 332.25%21.97M | 38.34%6.2M | 14.30%5.51M | 71.84%20.27M | --5.9M |
Cost of revenue | 34.83%29.62M | 307.54%29.79M | 341.04%30.47M | 154.07%65.68M | 288.31%29.5M | 239.40%21.97M | 17.79%7.31M | 23.87%6.91M | 66.28%25.85M | 7.6M |
Gross profit | -123,200.00%-1.23M | 330.94%2.58M | 111.21%157K | 7.21%-5.18M | -56.47%-2.66M | 100.07%1K | 35.47%-1.12M | -84.58%-1.4M | -48.76%-5.58M | -1.7M |
Operating expense | -88.25%7.41M | 131.18%27.83M | 225.23%34.63M | 190.22%131.55M | 231.86%45.84M | 548.60%63.02M | 6.29%12.04M | 1.67%10.65M | 53.13%45.33M | 13.81M |
Selling and administrative expenses | -97.18%1.7M | 97.58%22.17M | 180.81%27.62M | 163.33%110.7M | 132.03%29.49M | 569.27%60.15M | 5.77%11.22M | 1.09%9.84M | 57.82%42.04M | --12.71M |
-Selling and marketing expense | -71.69%1.28M | 33.78%2.58M | 115.85%3.01M | 92.33%10.03M | 38.81%2.18M | 227.71%4.53M | 70.23%1.93M | 23.25%1.39M | 38.19%5.21M | --1.57M |
-General and administrative expense | -99.25%415K | 110.80%19.6M | 191.54%24.61M | 173.38%100.67M | 145.15%27.32M | 631.33%55.62M | -1.93%9.3M | -1.83%8.44M | 61.06%36.82M | --11.14M |
Research and development costs | 98.47%5.71M | 593.38%5.66M | 763.18%7.01M | 533.93%20.85M | 1,384.47%16.34M | 294.11%2.88M | 13.97%816K | 9.29%812K | 10.96%3.29M | --1.1M |
Operating profit | 86.29%-8.64M | -92.01%-25.26M | -186.11%-34.47M | -168.59%-136.72M | -212.64%-48.5M | -467.42%-63.02M | -0.76%-13.15M | -7.27%-12.05M | -52.64%-50.9M | -15.51M |
Net non-operating interest income expense | -123.21%-2.09M | -264.00%-1.91M | -877.19%-1.67M | -398.15%-2.97M | -1,866.18%-1.34M | -23,275.00%-935K | -218.18%-525K | 52.50%-171K | 72.15%-596K | -68K |
Non-operating interest expense | 123.21%2.09M | 264.00%1.91M | 877.19%1.67M | 398.15%2.97M | 1,866.18%1.34M | 23,275.00%935K | 218.18%525K | -52.50%171K | -72.15%596K | --68K |
Other net income (expense) | 89.35%-1.51M | 100.49%150K | 89.59%-870K | -400.00%-114.31M | -638.81%-60.89M | -41.81%-14.22M | -457.40%-30.84M | -984.96%-8.35M | -7,676.19%-22.86M | -8.24M |
Gain on sale of security | 88.57%-1.25M | 99.49%-154K | 93.64%-515K | -81.26%-50.23M | 89.50%-804K | -12.08%-10.93M | -224.21%-30.4M | -774.30%-8.1M | -36,361.84%-27.71M | ---7.66M |
Special income (charges) | --0 | --0 | ---- | -1,114.47%-60.37M | ---60.05M | --63K | -109.83%-389K | ---- | 761.22%5.95M | --0 |
-Less:Impairment of capital assets | ---- | ---- | ---- | --60.05M | ---- | ---- | ---- | ---- | --0 | ---- |
-Less:Other special charges | ---- | ---- | ---- | 105.48%326K | --0 | ---63K | 109.83%389K | ---- | -761.22%-5.95M | --0 |
Other non- operating income (expenses) | 92.11%-265K | 733.33%304K | -37.60%-355K | -236.48%-3.71M | 92.45%-44K | -1,095.37%-3.36M | 57.89%-48K | -111.48%-258K | -21.23%-1.1M | ---583K |
Income before tax | 84.35%-12.24M | 39.31%-27.02M | -79.90%-37.01M | -241.57%-254M | -364.81%-110.73M | -269.82%-78.18M | -137.40%-44.52M | -93.23%-20.57M | -107.81%-74.36M | -23.82M |
Income tax | 99.61%-14K | -35K | -46K | -3.3M | 267K | -3.57M | 0 | 0 | 0 | 0 |
Net income | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M | -107.81%-74.36M | -23.82M |
Net income continuous Operations | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M | -107.81%-74.36M | ---23.82M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M | -107.81%-74.36M | -23.82M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M | -107.81%-74.36M | -23.82M |
Basic earnings per share | 90.16%-0.94 | 48.30%-2.31 | -14.61%-3.36 | -319.48%-44.45 | -200.56%-10.2029 | -217.02%-9.55 | -67.21%-4.4684 | -93.23%-2.9316 | -107.81%-10.5964 | -3.3946 |
Diluted earnings per share | 90.16%-0.94 | 48.30%-2.31 | -14.61%-3.36 | -319.48%-44.45 | -200.56%-10.2029 | -217.02%-9.55 | -67.21%-4.4684 | -93.23%-2.9316 | -107.81%-10.5964 | -3.3946 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |